CORT Investor ALERT: Corcept Therapeutics Inc. Investigated for Securities Fraud; Investors Should Contact Block & Leviton To Potentially Recover Losses

Group 1 - Block & Leviton is investigating Corcept Therapeutics Inc. for potential securities law violations following a significant drop in share price [1][2] - Corcept Therapeutics' shares fell over 50% on December 31, 2025, after the company received a Complete Response Letter from the FDA regarding relacorilant, indicating the need for additional evidence of effectiveness [2] - Investors who purchased Corcept Therapeutics common stock and experienced a loss may be eligible to participate in the investigation [3] Group 2 - Block & Leviton is assessing whether Corcept Therapeutics committed securities law violations and may file an action to recover losses for affected investors [4] - The firm encourages investors who have lost money to contact them for further information and assistance [5] - Whistleblowers with non-public information about Corcept Therapeutics are invited to assist in the investigation, with potential rewards for information leading to successful recovery [6] Group 3 - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7]